0001401708-21-000208.txt : 20210903
0001401708-21-000208.hdr.sgml : 20210903
20210903171324
ACCESSION NUMBER: 0001401708-21-000208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEECHEM JOSEPH M
CENTRAL INDEX KEY: 0001576195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 211237417
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 2000
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wf-form4_163070359044319.xml
FORM 4
X0306
4
2021-09-01
0
0001401708
NanoString Technologies Inc
NSTG
0001576195
BEECHEM JOSEPH M
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
0
1
0
0
SVP, Research & Development
Common Stock
2021-09-01
4
A
0
209
51.969
A
91384
D
Common Stock
2021-09-02
4
S
0
13000
60.83
D
78284
D
Common Stock
2021-09-02
4
S
0
10114
61.54
D
68270
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2021 through September 1, 2021. This transaction is also exempt under Rule 16b-3(c).
The Purchase Period ending September 1, 2021 is the PUrchase Period comprising the Offering Period (as defined in the ESPP) that began March 1, 2021 and ended September 1, 2021.
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2021.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $60.24 to $61.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $61.32 to $61.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
/s/ Shannon Atchison, Attorney-in-fact
2021-09-03